Chinese regulators give cosmetic surgery loans a nip and tuck
12 August 2021 - 10:16
byAgency Staff
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Chinese regulators have barred cosmetic surgery loans from structured debt products, a warning shot for the country’s big — and controversial — plastic surgery industry.
The Shanghai and Shenzhen stock exchanges banned consumer debt linked to cosmetic procedures from asset-backed securities traded on the exchanges, according to a person with knowledge of the matter. The rule applies to new issues and won’t take effect retroactively, said the person, who declined to be identified discussing non-public information. The move was first reported by Jiemian.
China’s booming cosmetic surgery industry joins a growing number of sectors under scrutiny in a wide-ranging crackdown aimed at reining in what the government sees as societal excess. The medical aesthetics industry tripled in value to 177-billion yuan from 2015 to 2019, according to a report from Deloitte China. Many of the clients are young people in lower-tier cities, enabled by apps that help prospective customers see how a modification might look, find surgeons or clinics, and finance the procedure.
The government has had the industry in its sights for a while, in particular, the estimated 60,000 clinics and 150,000 doctors who were operating without official licences as of 2017, according to Daxue Consulting.
Two months ago, the National Health Commission and several other government departments announced plans for a crackdown on illegal cosmetic surgery services in 2021, and the National Internet Finance Association of China issued a notice prohibiting financial institutions from co-operating with illegal cosmetic surgery institutions.
Spokespersons from the Shanghai and Shenzhen stock exchanges didn’t immediately respond to e-mailed requests for comment.
Bloomberg News. More stories like this are available on bloomberg.com
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Chinese regulators give cosmetic surgery loans a nip and tuck
Chinese regulators have barred cosmetic surgery loans from structured debt products, a warning shot for the country’s big — and controversial — plastic surgery industry.
The Shanghai and Shenzhen stock exchanges banned consumer debt linked to cosmetic procedures from asset-backed securities traded on the exchanges, according to a person with knowledge of the matter. The rule applies to new issues and won’t take effect retroactively, said the person, who declined to be identified discussing non-public information. The move was first reported by Jiemian.
China’s booming cosmetic surgery industry joins a growing number of sectors under scrutiny in a wide-ranging crackdown aimed at reining in what the government sees as societal excess. The medical aesthetics industry tripled in value to 177-billion yuan from 2015 to 2019, according to a report from Deloitte China. Many of the clients are young people in lower-tier cities, enabled by apps that help prospective customers see how a modification might look, find surgeons or clinics, and finance the procedure.
The government has had the industry in its sights for a while, in particular, the estimated 60,000 clinics and 150,000 doctors who were operating without official licences as of 2017, according to Daxue Consulting.
Two months ago, the National Health Commission and several other government departments announced plans for a crackdown on illegal cosmetic surgery services in 2021, and the National Internet Finance Association of China issued a notice prohibiting financial institutions from co-operating with illegal cosmetic surgery institutions.
Spokespersons from the Shanghai and Shenzhen stock exchanges didn’t immediately respond to e-mailed requests for comment.
Bloomberg News. More stories like this are available on bloomberg.com
JOHAN STEYN: Beauty is in the AI of the beholder
No bum deal for plastic surgeons as demand for butt implants rises
BIG READ: The warped self in the social media mirror
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
My brilliant career: Making the vulnerable smile, literally
J&J mulls shifting liabilities from baby powder suits to new company
Spike in palm oil prices is bad news for chocolate lovers
Great run for SA hair-care brands
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.